Cargando…
Nanosecond-pulsed DBD plasma treatment on human leukaemia Jurkat cells and monoblastic U937 cells in vitro
Plasma therapy offers an exciting and novel way of cancer treatment. Specifically, it is shown that Jurkat death rates are closely governed by the plasma treatment time. However, apart from time, alterations to different parameters of treatment process may yield better results. Here, Dielectric barr...
Autores principales: | Erfani, Rasool, Carmichael, Cameron, Sofokleous, Thea, Wang, Qiuyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012873/ https://www.ncbi.nlm.nih.gov/pubmed/35428374 http://dx.doi.org/10.1038/s41598-022-10056-8 |
Ejemplares similares
-
Evaluation of the Genetic Response of U937 and Jurkat Cells to 10-Nanosecond Electrical Pulses (nsEP)
por: Roth, Caleb C., et al.
Publicado: (2016) -
Cellular Processes Involved in Jurkat Cells Exposed to Nanosecond Pulsed Electric Field
por: Li, Huijuan, et al.
Publicado: (2019) -
Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells
por: Fritsch, Jürgen, et al.
Publicado: (2021) -
Enhanced Breakdown Strength and Thermal Conductivity of BN/EP Nanocomposites with Bipolar Nanosecond Pulse DBD Plasma Modified BNNSs
por: Mi, Yan, et al.
Publicado: (2019) -
The Polo-Like Kinase 1 (PLK1) Inhibitor NMS-P937 Is Effective in a New Model of Disseminated Primary CD56(+) Acute Monoblastic Leukaemia
por: Casolaro, Alessia, et al.
Publicado: (2013)